View Item 

Show simple item record

Obesity, transplantation, and bariatric surgery: An evolving solution for a growing epidemic
dc.contributor.authorDiwan, Tayyab S.
dc.contributor.authorLee, Tiffany C.
dc.contributor.authorNagai, Shunji
dc.contributor.authorBenedetti, Enrico
dc.contributor.authorPosselt, Andrew
dc.contributor.authorBumgardner, Ginny
dc.contributor.authorNoria, Sabrena
dc.contributor.authorWhitson, Bryan A.
dc.contributor.authorRatner, Lloyd
dc.contributor.authorMason, David
dc.contributor.authorFriedman, Jon
dc.contributor.authorWoodside, Kenneth J.
dc.contributor.authorHeimbach, Julie
dc.date.accessioned2020-08-10T20:55:06Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-08-10T20:55:06Z
dc.date.issued2020-08
dc.identifier.citationDiwan, Tayyab S.; Lee, Tiffany C.; Nagai, Shunji; Benedetti, Enrico; Posselt, Andrew; Bumgardner, Ginny; Noria, Sabrena; Whitson, Bryan A.; Ratner, Lloyd; Mason, David; Friedman, Jon; Woodside, Kenneth J.; Heimbach, Julie (2020). "Obesity, transplantation, and bariatric surgery: An evolving solution for a growing epidemic." American Journal of Transplantation 20(8): 2143-2155.
dc.identifier.issn1600-6135
dc.identifier.issn1600-6143
dc.identifier.urihttps://hdl.handle.net/2027.42/156201
dc.publisherWiley Periodicals, Inc.
dc.subject.otherclinical decision‐making
dc.subject.otherclinical research/practice
dc.subject.otherobesity
dc.subject.otherorgan transplantation in general
dc.subject.otherrecipient selection
dc.titleObesity, transplantation, and bariatric surgery: An evolving solution for a growing epidemic
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/156201/2/ajt15784.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/156201/1/ajt15784_am.pdfen_US
dc.identifier.doi10.1111/ajt.15784
dc.identifier.sourceAmerican Journal of Transplantation
dc.identifier.citedreferenceVilar‐Gomez E, Martinez‐Perez Y, Calzadilla‐Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015; 149 ( 2 ): 367 ‐ 378.e5; quiz e314–365.
dc.identifier.citedreferenceNesher E, Mor E, Shlomai A, et al. Simultaneous liver transplantation and sleeve gastrectomy: prohibitive combination or a necessity? Obes Surg. 2017; 27 ( 5 ): 1387 ‐ 1390.
dc.identifier.citedreferenceTariciotti L, D’Ugo S, Manzia TM, et al. Combined liver transplantation and sleeve gastrectomy for end‐stage liver disease in a bariatric patient: first european case‐report. Int J Surg Case Rep. 2016; 28: 38 ‐ 41.
dc.identifier.citedreferenceKumar S, Khandelwal N, Kumar A, et al. Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH‐related ESLD‐First report from India. Indian J Gastroenterol. 2017; 36 ( 3 ): 243 ‐ 247.
dc.identifier.citedreferenceAl‐Nowaylati A‐R, Al‐Haddad BJS, Dorman RB, et al. Gastric bypass after liver transplantation. Liver Transpl. 2013; 19 ( 12 ): 1324 ‐ 1329.
dc.identifier.citedreferenceOsseis M, Lazzati A, Salloum C, et al. Sleeve gastrectomy after liver transplantation: feasibility and outcomes. Obes Surg. 2018; 28 ( 1 ): 242 ‐ 248.
dc.identifier.citedreferenceKhoraki J, Katz MG, Funk LM, Greenberg JA, Fernandez LA, Campos GM. Feasibility and outcomes of laparoscopic sleeve gastrectomy after solid organ transplantation. Surg Obes Relat Dis. 2016; 12 ( 1 ): 75 ‐ 83.
dc.identifier.citedreferenceElli EF, Gonzalez‐Heredia R, Sanchez‐Johnsen L, Patel N, Garcia‐Roca R, Oberholzer J. Sleeve gastrectomy surgery in obese patients post‐organ transplantation. Surg Obes Relat Dis. 2016; 12 ( 3 ): 528 ‐ 534.
dc.identifier.citedreferenceWeiss ES, Allen JG, Russell SD, Shah AS, Conte JV. Impact of recipient body mass index on organ allocation and mortality in orthotopic heart transplantation. J Heart Lung Transplant. 2009; 28 ( 11 ): 1150 ‐ 1157.
dc.identifier.citedreferenceBaker AM, Levine TB, Goldberg AD, Levine AB. Natural history and predictors of obesity after orthotopic heart transplantation. J Heart Lung Transplant. 1992; 11 ( 6 ): 1156 ‐ 1159.
dc.identifier.citedreferenceHeilmann C, Stahl R, Schneider C, et al. Wound complications after median sternotomy: a single‐centre study. Interact Cardiovasc Thorac Surg. 2013; 16 ( 5 ): 643 ‐ 648.
dc.identifier.citedreferenceLandes G, Harris PG, Sampalis JS, et al. Outcomes in the management of sternal dehiscence by plastic surgery: a ten‐year review in one university center. Ann Plast Surg. 2007; 59 ( 6 ): 659 ‐ 666.
dc.identifier.citedreferenceOlbrecht VA, Barreiro CJ, Bonde PN, et al. Clinical outcomes of noninfectious sternal dehiscence after median sternotomy. Ann Thorac Surg. 2006; 82 ( 3 ): 902 ‐ 907.
dc.identifier.citedreferenceAkay MH, Nathan SS, Radovancevic R, et al. Obesity is associated with driveline infection of left ventricular assist devices. ASAIO J. 2019; 65 ( 7 ): 678 ‐ 682.
dc.identifier.citedreferenceKilic A, Conte JV, Shah AS, Yuh DD. Orthotopic heart transplantation in patients with metabolic risk factors. Ann Thorac Surg. 2012; 93 ( 3 ): 718 ‐ 724.
dc.identifier.citedreferenceMilaniak I, Przybylowski P, Wierzbicki K, Sadowski J. Post‐transplantation body mass index in heart transplant recipients: determinants and consequences. Transplant Proc. 2014; 46 ( 8 ): 2844 ‐ 2847.
dc.identifier.citedreferenceAllen JG, Arnaoutakis GJ, Weiss ES, Merlo CA, Conte JV, Shah AS. The impact of recipient body mass index on survival after lung transplantation. J Heart Lung Transplant. 2010; 29 ( 9 ): 1026 ‐ 1033.
dc.identifier.citedreferenceGries CJ, Bhadriraju S, Edelman JD, Goss CH, Raghu G, Mulligan MS. Obese patients with idiopathic pulmonary fibrosis have a higher 90‐day mortality risk with bilateral lung transplantation. J Heart Lung Transplant. 2015; 34 ( 2 ): 241 ‐ 246.
dc.identifier.citedreferenceRusso MJ, Hong KN, Davies RR, et al. The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines? Ann Surg. 2010; 251 ( 1 ): 144 ‐ 152.
dc.identifier.citedreferenceUpala S, Panichsillapakit T, Wijarnpreecha K, Jaruvongvanich V, Sanguankeo A. Underweight and obesity increase the risk of mortality after lung transplantation: a systematic review and meta‐analysis. Transpl Int. 2016; 29 ( 3 ): 285 ‐ 296.
dc.identifier.citedreferenceLederer DJ, Kawut SM, Wickersham N, et al. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med. 2011; 184 ( 9 ): 1055 ‐ 1061.
dc.identifier.citedreferenceChandrashekaran S, Keller CA, Kremers WK, Peters SG, Hathcock MA, Kennedy CC. Weight loss prior to lung transplantation is associated with improved survival. J Heart Lung Transplant. 2015; 34 ( 5 ): 651 ‐ 657.
dc.identifier.citedreferenceChaudhry UI, Kanji A, Sai‐Sudhakar CB, Higgins RS, Needleman BJ. Laparoscopic sleeve gastrectomy in morbidly obese patients with end‐stage heart failure and left ventricular assist device: medium‐term results. Surg Obes Relat Dis. 2015; 11 ( 1 ): 88 ‐ 93.
dc.identifier.citedreferenceHawkins RB, Go K, Raymond SL, Ayzengart A, Friedman J. Laparoscopic sleeve gastrectomy in patients with heart failure and left ventricular assist devices as a bridge to transplant. Surg Obes Relat Dis. 2018; 14 ( 9 ): 1269 ‐ 1273.
dc.identifier.citedreferenceArdila-Gatas J, Sharma G, Nor Hanipah Z, et al. Bariatric surgery in patients with interstitial lung disease. Surg Endosc. 2019; 33 ( 6 ): 1952 ‐ 1958.
dc.identifier.citedreferenceSheu EG, Channick R, Gee DW. Improvement in severe pulmonary hypertension in obese patients after laparoscopic gastric bypass or sleeve gastrectomy. Surg Endosc. 2016; 30 ( 2 ): 633 ‐ 637.
dc.identifier.citedreferenceLevitsky J, Formica RN, Bloom RD, et al. The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation. Am J Transplant. 2017; 17 ( 11 ): 2790 ‐ 2802.
dc.identifier.citedreferenceMarterre WF, Hariharan S, First MR, Alexander JW. Gastric bypass in morbidly obese kidney transplant recipients. Clin Transplant. 1996; 10 ( 5 ): 414 ‐ 419.
dc.identifier.citedreferenceRogers CC, Alloway RR, Alexander JW, Cardi M, Trofe J, Vinks AA. Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end‐stage renal disease and transplant patients: a pilot study. Clin Transplant. 2008; 22 ( 3 ): 281 ‐ 291.
dc.identifier.citedreferenceDiwan TS, Lichvar AB, Leino AD, et al. Pharmacokinetic and pharmacogenetic analysis of immunosuppressive agents after laparoscopic sleeve gastrectomy. Clin Transplant. 2017; 31 ( 6 ). https://doi.org/10.1111/ctr.12975.
dc.identifier.citedreferenceSafwan M, Collins KM, Abouljoud MS, Salgia R. Outcome of liver transplantation in patients with prior bariatric surgery. Liver Transpl. 2017; 23 ( 11 ): 1415 – 1421.
dc.identifier.citedreferenceTsamalaidze L, Stauffer JA, Arasi LC, et al. Laparoscopic sleeve gastrectomy for morbid obesity in patients after orthotopic liver transplant: a matched case-control study. Obes Surg. 2018; 28 ( 2 ): 444 – 450.
dc.identifier.citedreferenceKelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008; 32 ( 9 ): 1431 ‐ 1437.
dc.identifier.citedreferenceFlegal KM, Kruszon‐Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016; 315 ( 21 ): 2284 ‐ 2291.
dc.identifier.citedreferenceHubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26‐year follow‐up of participants in the Framingham Heart Study. Circulation. 1983; 67 ( 5 ): 968 ‐ 977.
dc.identifier.citedreferenceBray GA, Jablonski KA, Fujimoto WY, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr. 2008; 87 ( 5 ): 1212 ‐ 1218.
dc.identifier.citedreferenceRenehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body‐mass index and incidence of cancer: a systematic review and meta‐analysis of prospective observational studies. Lancet. 2008; 371 ( 9612 ): 569 ‐ 578.
dc.identifier.citedreferenceDiCecco SR, Francisco‐Ziller N. Obesity and organ transplantation: successes, failures, and opportunities. Nutr Clin Pract. 2014; 29 ( 2 ): 171 ‐ 191.
dc.identifier.citedreferenceRistow B, Rabkin J, Haeusslein E. Improvement in dilated cardiomyopathy after bariatric surgery. J Card Fail. 2008; 14 ( 3 ): 198 ‐ 202.
dc.identifier.citedreferenceSegev DL, Simpkins CE, Thompson RE, Locke JE, Warren DS, Montgomery RA. Obesity impacts access to kidney transplantation. J Am Soc Nephrol. 2008; 19 ( 2 ): 349 ‐ 355.
dc.identifier.citedreferenceWolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK. Body size, dose of hemodialysis, and mortality. Am J Kidney Dis. 2000; 35 ( 1 ): 80 ‐ 88.
dc.identifier.citedreferencePort FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol. 2002; 13 ( 4 ): 1061 ‐ 1066.
dc.identifier.citedreferencePostorino M, Marino C, Tripepi G, Zoccali C; CREDIT (Calabria Registry of Dialysis and Transplantation) Working Group. Abdominal obesity and all‐cause and cardiovascular mortality in end‐stage renal disease. J Am Coll Cardiol. 2009; 53 ( 15 ): 1265 ‐ 1272.
dc.identifier.citedreferenceStefan N, Artunc F, Heyne N, Machann J, Schleicher ED, Haring HU. Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys. Nephrol Dial Transplant. 2016; 31 ( 5 ): 726 ‐ 730.
dc.identifier.citedreferenceStefansson VTN, Schei J, Solbu MD, Jenssen TG, Melsom T, Eriksen BO. Metabolic syndrome but not obesity measures are risk factors for accelerated age‐related glomerular filtration rate decline in the general population. Kidney Int. 2018; 93 ( 5 ): 1183 ‐ 1190.
dc.identifier.citedreferenceCerhan JR, Moore SC, Jacobs EJ, et al. A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin Proc. 2014; 89 ( 3 ): 335 ‐ 345.
dc.identifier.citedreferenceBeddhu S, Pappas LM, Ramkumar N, Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol. 2003; 14 ( 9 ): 2366 ‐ 2372.
dc.identifier.citedreferenceKovesdy CP, Czira ME, Rudas A, et al. Body mass index, waist circumference and mortality in kidney transplant recipients. Am J Transplant. 2010; 10 ( 12 ): 2644 ‐ 2651.
dc.identifier.citedreferenceMolnar MZ, Streja E, Kovesdy CP, et al. Associations of body mass index and weight loss with mortality in transplant‐waitlisted maintenance hemodialysis patients. Am J Transplant. 2011; 11 ( 4 ): 725 ‐ 736.
dc.identifier.citedreferenceDelgado C, Chertow GM, Kaysen GA, et al. Associations of body mass index and body fat with markers of inflammation and nutrition among patients receiving hemodialysis. Am J Kidney Dis. 2017; 70 ( 6 ): 817 ‐ 825.
dc.identifier.citedreferenceStenvinkel P, Gillespie IA, Tunks J, et al. Inflammation modifies the paradoxical association between body mass index and mortality in hemodialysis patients. J Am Soc Nephrol. 2016; 27 ( 5 ): 1479 ‐ 1486.
dc.identifier.citedreferenceGill JS, Lan J, Dong J, et al. The survival benefit of kidney transplantation in obese patients. Am J Transplant. 2013; 13 ( 8 ): 2083 ‐ 2090.
dc.identifier.citedreferenceLentine KL, Delos Santos R, Axelrod D, Schnitzler MA, Brennan DC, Tuttle‐Newhall JE. Obesity and kidney transplant candidates: how big is too big for transplantation? Am J Nephrol. 2012; 36 ( 6 ): 575 ‐ 586.
dc.identifier.citedreferenceChan G, Soucisse M. Survey of Canadian Kidney Transplant specialists on the management of morbid obesity and the transplant waiting list. Can J Kidney Health Dis. 2016; 3: 2054358116675344.
dc.identifier.citedreferenceStenvinkel P, Ikizler TA, Mallamaci F, Zoccali C. Obesity and nephrology: results of a knowledge and practice pattern survey. Nephrol Dial Transplant. 2013; 28 ( Suppl 4 ): iv99 ‐ iv104.
dc.identifier.citedreferenceGill JS, Hendren E, Dong J, Johnston O, Gill J. Differential association of body mass index with access to kidney transplantation in men and women. Clin J Am Soc Nephrol. 2014; 9 ( 5 ): 951 ‐ 959.
dc.identifier.citedreferenceSchold JD, Buccini LD, Poggio ED, Flechner SM, Goldfarb DA. Association of candidate removals from the kidney transplant waiting list and center performance oversight. Am J Transplant. 2016; 16 ( 4 ): 1276 ‐ 1284.
dc.identifier.citedreferencePelletier SJ, Maraschio MA, Schaubel DE, et al. Survival benefit of kidney and liver transplantation for obese patients on the waiting list. Clin Transpl. 2003; 17: 77 ‐ 88.
dc.identifier.citedreferenceKrishnan N, Higgins R, Short A, et al. Kidney transplantation significantly improves patient and graft survival irrespective of BMI: a cohort study. Am J Transplant. 2015; 15 ( 9 ): 2378 ‐ 2386.
dc.identifier.citedreferenceHoogeveen EK, Aalten J, Rothman KJ, et al. Effect of obesity on the outcome of kidney transplantation: a 20‐year follow‐up. Transplantation. 2011; 91 ( 8 ): 869 ‐ 874.
dc.identifier.citedreferenceMeier‐Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation. 2002; 73 ( 1 ): 70 ‐ 74.
dc.identifier.citedreferenceTerjimanian MN, Underwood PW, Cron DC, et al. Morphometric age and survival following kidney transplantation. Clin Transplant. 2017; 31 ( 10 ). https://doi.org/10.1111/ctr.13066.
dc.identifier.citedreferenceChang SH, Coates PT, McDonald SP. Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation. 2007; 84 ( 8 ): 981 ‐ 987.
dc.identifier.citedreferenceChang SH, McDonald SP. Post‐kidney transplant weight change as marker of poor survival outcomes. Transplantation. 2008; 85 ( 10 ): 1443 ‐ 1448.
dc.identifier.citedreferenceLim WH, Wong G, Pilmore HL, McDonald SP, Chadban SJ. Long‐term outcomes of kidney transplantation in people with type 2 diabetes: a population cohort study. Lancet Diabetes Endocrinol. 2017; 5 ( 1 ): 26 ‐ 33.
dc.identifier.citedreferenceWu D, Dawson NA, Levings MK. Obesity‐associated adipose tissue inflammation and transplantation. Am J Transplant. 2016; 16 ( 3 ): 743 ‐ 750.
dc.identifier.citedreferenceCannon RM, Jones CM, Hughes MG, Eng M, Marvin MR. The impact of recipient obesity on outcomes after renal transplantation. Ann Surg. 2013; 257 ( 5 ): 978 ‐ 984.
dc.identifier.citedreferenceNicoletto BB, Fonseca NK, Manfro RC, Goncalves LF, Leitao CB, Souza GC. Effects of obesity on kidney transplantation outcomes: a systematic review and meta‐analysis. Transplantation. 2014; 98 ( 2 ): 167 ‐ 176.
dc.identifier.citedreferenceGore JL, Pham PT, Danovitch GM, et al. Obesity and outcome following renal transplantation. Am J Transplant. 2006; 6 ( 2 ): 357 ‐ 363.
dc.identifier.citedreferenceel‐Agroudy AE, Wafa EW, Gheith OE, Shehab el‐Dein AB, Ghoneim MA. Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation. 2004; 77 ( 9 ): 1381 ‐ 1385.
dc.identifier.citedreferenceCron DC, Noon KA, Cote DR, et al. Using analytic morphomics to describe body composition associated with post‐kidney transplantation diabetes mellitus. Clin Transplant. 2017; 31 ( 9 ): e13040.
dc.identifier.citedreferenceAndrews LM, de Winter BCM, Tang J‐T, et al. Overweight kidney transplant recipients are at risk of being overdosed following standard bodyweight‐based tacrolimus starting dose. Transplant Direct. 2017; 3 ( 2 ): e129.
dc.identifier.citedreferenceHumar A, Ramcharan T, Denny R, Gillingham KJ, Payne WD, Matas AJ. Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation. 2001; 72 ( 12 ): 1920 ‐ 1923.
dc.identifier.citedreferenceLynch RJ, Ranney DN, Shijie C, Lee DS, Samala N, Englesbe MJ. Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg. 2009; 250 ( 6 ): 1014 ‐ 1020.
dc.identifier.citedreferenceZaydfudim V, Feurer ID, Moore DR, Moore DE, Pinson CW, Shaffer D. Pre‐transplant overweight and obesity do not affect physical quality of life after kidney transplantation. J Am Coll Surg. 2010; 210 ( 3 ): 336 ‐ 344.
dc.identifier.citedreferenceKim Y, Chang AL, Wima K, et al. The impact of morbid obesity on resource utilization after renal transplantation. Surgery. 2016; 160 ( 6 ): 1544 ‐ 1550.
dc.identifier.citedreferenceSood A, Hakim DN, Hakim NS. Consequences of recipient obesity on postoperative outcomes in a renal transplant: a systematic review and meta‐analysis. Exp Clin Transplant. 2016; 14 ( 2 ): 121 ‐ 128.
dc.identifier.citedreferenceOberholzer J, Giulianotti P, Danielson KK, et al. Minimally invasive robotic kidney transplantation for obese patients previously denied access to transplantation. Am J Transplant. 2013; 13 ( 3 ): 721 ‐ 728.
dc.identifier.citedreferenceTzvetanov I, D’Amico G, Benedetti E. Robotic‐assisted kidney transplantation: our experience and literature review. Curr Transplant Rep. 2015; 2 ( 2 ): 122 ‐ 126.
dc.identifier.citedreferenceModi P, Pal B, Modi J, et al. Retroperitoneoscopic living‐donor nephrectomy and laparoscopic kidney transplantation: experience of initial 72 cases. Transplantation. 2013; 95 ( 1 ): 100 ‐ 105.
dc.identifier.citedreferenceModanlou KA, Muthyala U, Xiao H, et al. Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation. 2009; 87 ( 8 ): 1167 ‐ 1173.
dc.identifier.citedreferenceSheetz KH, Woodside KJ, Shahinian VB, Dimick JB, Montgomery JR, Waits SA. Trends in bariatric surgery procedures among patients with ESKD in the United States. Clin J Am Soc Nephrol. 2019; 14 ( 8 ): 1193 ‐ 1199.
dc.identifier.citedreferenceMozer AB, Pender JR, Chapman WHH, Sippey ME, Pories WJ, Spaniolas K. Bariatric surgery in patients with dialysis‐dependent renal failure. Obes Surg. 2015; 25 ( 11 ): 2088 ‐ 2092.
dc.identifier.citedreferenceKassam A‐F, Mirza A, Kim Y, et al. Long‐term outcomes in patients with obesity and renal disease after sleeve gastrectomy. Am J Transplant. 2019. https://doi.org/10.1111/ajt.15650.
dc.identifier.citedreferenceFriedman AN, Wahed AS, Wang J, et al. Effect of bariatric surgery on CKD risk. J Am Soc Nephrol. 2018; 29 ( 4 ): 1289 ‐ 1300.
dc.identifier.citedreferenceFreeman CM, Woodle ES, Shi J, et al. Addressing morbid obesity as a barrier to renal transplantation with laparoscopic sleeve gastrectomy. Am J Transplant. 2015; 15 ( 5 ): 1360 ‐ 1368.
dc.identifier.citedreferenceLin MYC, Mehdi Tavakol M, Sarin A, et al. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis. 2013; 9 ( 5 ): 653 ‐ 658.
dc.identifier.citedreferenceKim Y, Jung AD, Dhar VK, et al. Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients. Am J Transplant. 2018; 18 ( 2 ): 410 ‐ 416.
dc.identifier.citedreferenceYemini R, Nesher E, Winkler J, et al. Bariatric surgery in solid organ transplant patients: Long‐term follow‐up results of outcome, safety, and effect on immunosuppression. Am J Transplant. 2018; 18 ( 11 ): 2772 ‐ 2780.
dc.identifier.citedreferenceCohen JB, Lim MA, Tewksbury CM, et al. Bariatric surgery before and after kidney transplantation: long‐term weight loss and allograft outcomes. Surg Obes Relat Dis. 2019; 15 ( 6 ): 935 ‐ 941.
dc.identifier.citedreferenceAscha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010; 51 ( 6 ): 1972 ‐ 1978.
dc.identifier.citedreferenceChalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non‐alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012; 142 ( 7 ): 1592 ‐ 1609.
dc.identifier.citedreferenceRinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015; 313 ( 22 ): 2263 ‐ 2273.
dc.identifier.citedreferenceWong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015; 148 ( 3 ): 547 ‐ 555.
dc.identifier.citedreferenceSingal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation. 2013; 95 ( 5 ): 755 ‐ 760.
dc.identifier.citedreferenceSegev DL, Thompson RE, Locke JE, et al. Prolonged waiting times for liver transplantation in obese patients. Ann Surg. 2008; 248 ( 5 ): 863 ‐ 870.
dc.identifier.citedreferenceNair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology. 2002; 35 ( 1 ): 105 ‐ 109.
dc.identifier.citedreferenceLeonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M. The impact of obesity on long‐term outcomes in liver transplant recipients‐results of the NIDDK liver transplant database. Am J Transplant. 2008; 8 ( 3 ): 667 ‐ 672.
dc.identifier.citedreferenceDick AAS, Spitzer AL, Seifert CF, et al. Liver transplantation at the extremes of the body mass index. Liver Transpl. 2009; 15 ( 8 ): 968 ‐ 977.
dc.identifier.citedreferenceOrci LA, Majno PE, Berney T, Morel P, Mentha G, Toso C. The impact of wait list body mass index changes on the outcome after liver transplantation. Transpl Int. 2013; 26 ( 2 ): 170 ‐ 176.
dc.identifier.citedreferencePagadala M, Dasarathy S, Eghtesad B, McCullough AJ. Posttransplant metabolic syndrome: an epidemic waiting to happen. Liver Transpl. 2009; 15 ( 12 ): 1662 ‐ 1670.
dc.identifier.citedreferenceLaryea M, Watt KD, Molinari M, et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl. 2007; 13 ( 8 ): 1109 ‐ 1114.
dc.identifier.citedreferenceWatt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post‐liver transplant: results of the NIDDK long‐term follow‐up study. Am J Transplant. 2010; 10 ( 6 ): 1420 ‐ 1427.
dc.identifier.citedreferenceLaMattina JC, Foley DP, Fernandez LA, et al. Complications associated with liver transplantation in the obese recipient. Clin Transplant. 2012; 26 ( 6 ): 910 ‐ 918.
dc.identifier.citedreferenceSpengler EK, O’Leary JG, Te HS, et al. Liver transplantation in the obese cirrhotic patient. Transplantation. 2017; 101 ( 10 ): 2288 ‐ 2296.
dc.identifier.citedreferenceHakeem AR, Cockbain AJ, Raza SS, et al. Increased morbidity in overweight and obese liver transplant recipients: a single‐center experience of 1325 patients from the United Kingdom. Liver Transpl. 2013; 19 ( 5 ): 551 ‐ 562.
dc.identifier.citedreferenceSinghal A, Wilson GC, Wima K, et al. Impact of recipient morbid obesity on outcomes after liver transplantation. Transpl Int. 2015; 28 ( 2 ): 148 ‐ 155.
dc.identifier.citedreferenceSawyer RG, Pelletier SJ, Pruett TL. Increased early morbidity and mortality with acceptable long‐term function in severely obese patients undergoing liver transplantation. Clin Transplant. 1999; 13 ( 1 Pt 2 ): 126 ‐ 130.
dc.identifier.citedreferenceBambha KM, Dodge JL, Gralla J, Sprague D, Biggins SW. Low, rather than high, body mass index confers increased risk for post‐liver transplant death and graft loss: risk modulated by model for end‐stage liver disease. Liver Transpl. 2015; 21 ( 10 ): 1286 ‐ 1294.
dc.identifier.citedreferenceSchlansky B, Naugler WE, Orloff SL, Enestvedt CK. Higher mortality and survival benefit in obese patients awaiting liver transplantation. Transplantation. 2016; 100 ( 12 ): 2648 ‐ 2655.
dc.identifier.citedreferenceSaab S, Lalezari D, Pruthi P, Alper T, Tong MJ. The impact of obesity on patient survival in liver transplant recipients: a meta‐analysis. Liver Int. 2015; 35 ( 1 ): 164 ‐ 170.
dc.identifier.citedreferenceQuillin RC, Wilson GC, Sutton JM, et al. Increasing prevalence of nonalcoholic steatohepatitis as an indication for liver transplantation. Surgery. 2014; 156 ( 4 ): 1049 ‐ 1056.
dc.identifier.citedreferenceAgopian VG, Kaldas FM, Hong JC, et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg. 2012; 256 ( 4 ): 624 ‐ 633.
dc.identifier.citedreferenceKennedy C, Redden D, Gray S, et al. Equivalent survival following liver transplantation in patients with non‐alcoholic steatohepatitis compared with patients with other liver diseases. HPB (Oxford). 2012; 14 ( 9 ): 625 ‐ 634.
dc.identifier.citedreferenceDiwan TS, Rice TC, Heimbach JK, Schauer DP. Liver transplantation and bariatric surgery: timing and outcomes. Liver Transpl. 2018; 24 ( 9 ): 1280 ‐ 1287.
dc.identifier.citedreferenceHayashi F, Matsumoto Y, Momoki C, et al. Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis. Hepatol Res. 2013; 43 ( 12 ): 1264 ‐ 1275.
dc.identifier.citedreferenceHickman IJ, Jonsson JR, Prins JB, et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut. 2004; 53 ( 3 ): 413 ‐ 419.
dc.identifier.citedreferenceKonishi I, Hiasa Y, Tokumoto Y, et al. Aerobic exercise improves insulin resistance and decreases body fat and serum levels of leptin in patients with hepatitis C virus. Hepatol Res. 2011; 41 ( 10 ): 928 ‐ 935.
dc.identifier.citedreferenceHeimbach JK, Watt KDS, Poterucha JJ, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end‐stage liver disease. Am J Transplant. 2013; 13 ( 2 ): 363 ‐ 368.
dc.identifier.citedreferenceGlass LM, Dickson RC, Anderson JC, et al. Total body weight loss of >/= 10 % is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis. Dig Dis Sci. 2015; 60 ( 4 ): 1024 ‐ 1030.
dc.identifier.citedreferenceTakata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008; 4 ( 2 ): 159 ‐ 164; discussion 164–155.
dc.identifier.citedreferenceZamora‐Valdes D, Watt KD, Kellogg TA, et al. Long‐term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy. Hepatology. 2018; 68 ( 2 ): 485 ‐ 495.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ajt15784_am.pdf
Size:
392.8KB
Format:
PDF
View/Open
Name:
ajt15784.pdf
Size:
658.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.